SAMOTOLISIB

UNII:	C88817F47Y
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₃H₂₆N₄O₃
Preferred Substance Name:	SAMOTOLISIB
InChIKey:	ACCFLVVUVBJNGT-AWEZNQCLSA-N
GSRS Full Record:	C88817F47Y i

1386874-06-1
2H-IMIDAZO(4,5-C)QUINOLIN-2-ONE, 1,3-DIHYDRO-8-(5-(1-HYDROXY-1-METHYLETHYL)-3-PYRIDINYL)-1-((2S)-2-METHOXYPROPYL)-3-METHYL-
8-[5-(2-Hydroxypropan-2-yl)pyridin-3-yl]-1-[(2S)-2-methoxypropyl]-3-methyl-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one
8-[5-(2-hydroxypropan-2-yl)-3-pyridinyl]-1-[(2S)-2-methoxypropyl]-3-methylimidazo[4,5-c]quinolin-2-one
8-[5-(2-hydroxypropan-2-yl)-3-pyridinyl]-1-[(2S)-2-methoxypropyl]-3-methylimidazo[4,5-c]quinolin-2-one
LY-3023414
LY3023414
PI3K/MTOR INHIBITOR LY3023414
SAMOTOLISIB [USAN]
Samotolisib [WHO-DD]
samotolisib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

SAMOTOLISIB

Synonyms and Mappings

Resources